Trial intelligence / Profile preview

Midazolam Hydrochloride Oral Solution for Procedural and Preoperative Sedation in Children (Phase IV, Single-Arm, China)

CTR20251318Phase 4Completed

Sponsor
Jiangsu Nhwa Pharmaceutical
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of midazolam in anxiety disorder, preoperative anxiety, sponsored by Jiangsu Nhwa Pharmaceutical. Started Apr 2025; status: completed.

02

Drugs

midazolam
03

Conditions

anxiety disorderpreoperative anxiety

Beyond the preview

Go deeper on CTR20251318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20251318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call